OCB

Rt-Pcr Multigene Expression Test, Sentinel Lymph Node, Cancer Metastasis Detection

Product code
OCB
Device name
Rt-Pcr Multigene Expression Test, Sentinel Lymph Node, Cancer Metastasis Detection
Device class
Class 3
Medical specialty
Unknown
Marketing pathway
PMA
Flag
Life-sustaining / life-supporting

FDA classification definition

A gene expression test for detection of cancer metastasisis an in vitro diagnostic test performed on tissue of interest from patients previously diagnosed with cancer. Results from the test can be used to guide the intra-operative or post-operative decision to remove additional tissue. Post-operative histological evaluation of permanent sections of the tissue specimen, in accordance with usual diagnostic practice and using an appropriate histological sampling scheme, is required.

Definition text from the FDA device classification database (U.S. federal government work, public domain).

Official FDA classification page: OCB
Classification and pathway per current FDA publications. Data from openFDA (CC0).